Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance

BACKGROUND: Thromboembolic events constitute a major health problem, despite the steadily expanding arsenal of antiplatelet drugs. Hence, there is still a need to optimize the antiplatelet therapy. OBJECTIVES: The aim of our study was to verify a hypothesis that there are no differences in platelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakubowski, M., Dębski, J., Szahidewicz-Krupska, E., Turek-Jakubowska, A., Gawryś, J., Gawryś, K., Skomro, R., Derkacz, A., Doroszko, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635279/
https://www.ncbi.nlm.nih.gov/pubmed/29090039
http://dx.doi.org/10.1155/2017/3132063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635279/
https://www.ncbi.nlm.nih.gov/pubmed/29090039
http://dx.doi.org/10.1155/2017/3132063

Ejemplares similares